Lennox-Gastaut syndrome becomes second Epidyolex indication to be listed on PBS by Steve Jones June 5, 2023April 30, 2024 Epidyolex has been listed on the Pharmaceutical Benefits Scheme (PBS) for the treatment of Lennox-Gastaut Syndrome […]
Creditors advised to wind up BBS Pharmaceuticals as investigations continue into firm’s financial affairs by Steve Jones June 1, 2023April 30, 2024
Overseas manufacturers in bid to supply non-compliant product for ‘limited period’ beyond July 1 by Steve Jones May 31, 2023April 30, 2024
Bod Science to test drug-delivery tech on psychiatric medication by Steve Jones May 31, 2023April 30, 2024
NZ study finds cannabis users reduced reliance on opioid medication by Steve Jones May 30, 2023April 30, 2024
Vitura director nets A$6m after selling 14% of his stake in the company by Steve Jones May 25, 2023April 30, 2024
TGA rejects inconsistency charge amid 16 ‘active and in-depth’ advertising investigations by Steve Jones May 25, 2023April 30, 2024
Doctors warn of child health risk as TGA tightens rules on SAS-B approvals by Steve Jones May 18, 2023April 30, 2024
It turns out ‘one million people’ can be wrong, but ‘fake news’ isn’t always bad by Martin Lane May 17, 2023April 30, 2024
